Evertrust

Evertrust Biopharma is a clinical-stage biotechnology company focused on the development of innovative immune cell therapies for the treatment of cancer. The company leverages its proprietary technology platforms to engineer CAR-T, TCR-T, and NK cell therapies designed to target both hematological malignancies and challenging solid tumors. Evertrust's pipeline includes several candidates currently in early-stage clinical trials, with a primary focus on improving the efficacy and safety of cell-based immunotherapies. Headquartered in Beijing, the company aims to address significant unmet medical needs in oncology through advanced genetic engineering and cell manufacturing processes.